Chi‐Mu Chuang

1.2k total citations
19 papers, 801 citations indexed

About

Chi‐Mu Chuang is a scholar working on Immunology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Chi‐Mu Chuang has authored 19 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 6 papers in Reproductive Medicine and 5 papers in Molecular Biology. Recurrent topics in Chi‐Mu Chuang's work include Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and MicroRNA in disease regulation (3 papers). Chi‐Mu Chuang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and MicroRNA in disease regulation (3 papers). Chi‐Mu Chuang collaborates with scholars based in Taiwan, United States and China. Chi‐Mu Chuang's co-authors include Lu‐Hai Wang, Kuan‐Chong Chao, Kuan-Chong Chao, Yen‐Hou Chang, Pi‐Lin Sung, Jyh‐Yih Chen, Chun-Yi Lin, T.‐C. Wu, Cheng-Tao Lin and Kai‐Ti Lin and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Chi‐Mu Chuang

19 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Mu Chuang Taiwan 13 386 313 218 185 136 19 801
Canhui Cao China 16 443 1.1× 229 0.7× 128 0.6× 213 1.2× 77 0.6× 55 821
Susann Busch Sweden 12 371 1.0× 148 0.5× 275 1.3× 171 0.9× 57 0.4× 15 716
Rosalía I. Cordo Russo Argentina 14 432 1.1× 154 0.5× 547 2.5× 203 1.1× 138 1.0× 27 1.1k
Yuanming Shen China 15 681 1.8× 601 1.9× 111 0.5× 151 0.8× 95 0.7× 35 1.0k
Ling Xi China 15 259 0.7× 68 0.2× 95 0.4× 204 1.1× 62 0.5× 36 588
Martina Ring Ireland 13 649 1.7× 474 1.5× 93 0.4× 160 0.9× 43 0.3× 19 974
Gufeng Xu China 12 313 0.8× 178 0.6× 202 0.9× 84 0.5× 98 0.7× 40 628
Ha Zhu China 10 305 0.8× 214 0.7× 304 1.4× 165 0.9× 44 0.3× 12 624
Yafang Lin China 7 373 1.0× 128 0.4× 65 0.3× 129 0.7× 338 2.5× 12 752
Annemarie Wiedemair Austria 14 518 1.3× 268 0.9× 51 0.2× 231 1.2× 67 0.5× 16 806

Countries citing papers authored by Chi‐Mu Chuang

Since Specialization
Citations

This map shows the geographic impact of Chi‐Mu Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Mu Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Mu Chuang more than expected).

Fields of papers citing papers by Chi‐Mu Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Mu Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Mu Chuang. The network helps show where Chi‐Mu Chuang may publish in the future.

Co-authorship network of co-authors of Chi‐Mu Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Mu Chuang. A scholar is included among the top collaborators of Chi‐Mu Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Mu Chuang. Chi‐Mu Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Tian‐Li, et al.. (2023). Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance. Journal of Experimental & Clinical Cancer Research. 42(1). 171–171. 48 indexed citations
2.
Lin, Wen‐Chun, Yun‐Ru Chen, Chi‐Mu Chuang, & Jyh‐Yih Chen. (2022). A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms. Frontiers in Microbiology. 13. 806654–806654. 13 indexed citations
3.
Lin, Sheng‐Chieh, Yi-Chu Liao, Po‐Ming Chen, et al.. (2022). Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling. Journal of Biomedical Science. 29(1). 109–109. 76 indexed citations
4.
Shen, Yao, Jin Gyoung Jung, Geoffrey D. Shimberg, et al.. (2021). Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy. iScience. 24(11). 103297–103297. 17 indexed citations
5.
Chuang, Chi‐Mu, et al.. (2021). Changes in Depression and Sleep Quality and Associated Factors in Women Receiving Chemotherapy for Ovarian Cancer. Cancer Nursing. 45(4). 271–279. 7 indexed citations
6.
Chang, Yilin, Chi‐Mu Chuang, Ching‐Hui Chien, et al.. (2020). Factors related to changes in resilience and distress in women with endometrial cancer. Archives of Women s Mental Health. 24(3). 413–421. 10 indexed citations
7.
Huang, Han-Ning, Chi‐Mu Chuang, Jyh‐Yih Chen, & Chieh‐Yu Pan. (2018). Epinecidin-1: A marine fish antimicrobial peptide with therapeutic potential against Trichomonas vaginalis infection in mice. Peptides. 112. 139–148. 22 indexed citations
8.
Chang, Chia-Ming, Chia-Ming Chang, Yi‐Ping Yang, et al.. (2017). Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis. International Journal of Molecular Sciences. 18(11). 2345–2345. 21 indexed citations
9.
11.
Lin, Chun-Yi, et al.. (2015). Increased Association Between Endometriosis and Endometrial Cancer. International Journal of Gynecological Cancer. 25(3). 447–452. 59 indexed citations
12.
Wang, Peng‐Hui, Chi‐Mu Chuang, Yi-Wen Chang, et al.. (2015). Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population. Taiwanese Journal of Obstetrics and Gynecology. 54(2). 122–125. 4 indexed citations
13.
Shen, Yao, Changsheng Liu, Yen‐Hou Chang, et al.. (2015). Subtype-specific binding peptides enhance the therapeutic efficacy of nanomedicine in the treatment of ovarian cancer. Cancer Letters. 360(1). 39–47. 5 indexed citations
14.
Lin, Kai‐Ti, Chi‐Mu Chuang, Scarlett Y. Yang, et al.. (2015). Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nature Communications. 6(1). 5917–5917. 90 indexed citations
15.
Sung, Pi‐Lin, Yen‐Hou Chang, Kuan-Chong Chao, & Chi‐Mu Chuang. (2014). Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review. Gynecologic Oncology. 133(2). 147–154. 74 indexed citations
16.
Chang, Cheng‐Chang, et al.. (2013). MicroRNAs regulate several functions of normal tissues and malignancies. Taiwanese Journal of Obstetrics and Gynecology. 52(4). 465–469. 17 indexed citations
18.
Chuang, Chi‐Mu, et al.. (2013). MicroRNA‐138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF‐1α. International Journal of Cancer. 133(4). 867–878. 194 indexed citations
19.
Tseng, Chih-Wen, Chien‐Fu Hung, Ronald D. Alvarez, et al.. (2008). Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell–Mediated Antitumor Immunity Induced by DNA Vaccination. Clinical Cancer Research. 14(10). 3185–3192. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026